Skip to main content
Top
Published in: BMC Gastroenterology 1/2006

Open Access 01-12-2006 | Research article

Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany

Authors: Clemens Schafmayer, Jürgen Hartleb, Jürgen Tepel, Stefan Albers, Sandra Freitag, Henry Völzke, Stephan Buch, Markus Seeger, Birgit Timm, Bernd Kremer, Ulrich R Fölsch, Fred Fändrich, Michael Krawczak, Stefan Schreiber, Jochen Hampe

Published in: BMC Gastroenterology | Issue 1/2006

Login to get access

Abstract

Background

Gallstones represent a prevalent and costly health problem. The changing epidemiology and the emerging non-surgical interventions for gallstone disease necessitate the definition of target populations for future therapies. This study aimed to define patterns of gallstone composition and identify demographic predictors of gallstone composition in a large sample of symptomatic gallstones from Northern Germany.

Methods

One thousand and seventy-four post-cholecystectomy gallstone specimens were obtained. Demographic and clinical information was provided by questionnaire (N = 1025 independent individuals with complete information). Two samples from each gallstone were analyzed using Fourier transformed infrared spectrometry.

Results

The most prevalent substance was cholesterol, which was detected in 95.0% of gallstone specimens. Bilirubin and bilirubinate were present in 30.0% and calcium was detected in 10.0% of the spectra. Ninety-two percent of measurements from the same stone yielded the same "main" substances, indicating a homogenous stone composition in most cases. Female sex and higher body mass index (BMI) were associated with the presence of cholesterol as a main substance in the gallstones (p < 0.001).

Conclusion

The changing epidemiology of gallstone disease is reflected by a marked shift in stone composition: Only two percent of stones in this study were pigment stones as compared to 91% percent of stones containing cholesterol as a main substance. Obese individuals from Germany with a BMI > 30 kg/m2 have in 95% cholesterol-dominant gallstones and represent a potential target population for non-surgical interventions for the prevention or treatment of cholesterol stones.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lammert F, Sauerbruch T: Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005, 2: 423-433. 10.1038/ncpgasthep0257.CrossRefPubMed Lammert F, Sauerbruch T: Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005, 2: 423-433. 10.1038/ncpgasthep0257.CrossRefPubMed
2.
go back to reference Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM: Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 2005, 71: 97-105. 10.1159/000084525.CrossRefPubMed Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM: Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 2005, 71: 97-105. 10.1159/000084525.CrossRefPubMed
4.
go back to reference BQS Bundesgeschäftsstelle Qualitätssicherung: Cholezystektomie. Qualität sichtbar machen BQS-Qualitätsreport 2004. Edited by: BQS Bundesgeschäftsstelle Qualitätssicherung. 2004, Düsseldorf, , 22-34. BQS Bundesgeschäftsstelle Qualitätssicherung: Cholezystektomie. Qualität sichtbar machen BQS-Qualitätsreport 2004. Edited by: BQS Bundesgeschäftsstelle Qualitätssicherung. 2004, Düsseldorf, , 22-34.
5.
go back to reference Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R: The burden of selected digestive diseases in the United States. Gastroenterology. 2002, 122: 1500-1511. 10.1053/gast.2002.32978.CrossRefPubMed Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R: The burden of selected digestive diseases in the United States. Gastroenterology. 2002, 122: 1500-1511. 10.1053/gast.2002.32978.CrossRefPubMed
6.
go back to reference National Institutes of Health: Gallbladder and biliary disease. Action plan for liver disease research A report of the Liver Diseases Subcommittee of the Digestive Diseases Interagency Coordinating Committee. Edited by: U.S. Department of Health and Human Services. 2005, Bethesda, NIH, 144-150. National Institutes of Health: Gallbladder and biliary disease. Action plan for liver disease research A report of the Liver Diseases Subcommittee of the Digestive Diseases Interagency Coordinating Committee. Edited by: U.S. Department of Health and Human Services. 2005, Bethesda, NIH, 144-150.
7.
go back to reference Venneman NG, Renooij W, Rehfeld JF, van Berge-Henegouwen GP, Go PMNYH, Broeders IAMJ, van Erpecum KJ: Small Gallstones, Preserved Gallbladder Motility, and Fast Crystallization Are Associated with Pancreatitis. Hepatology. 2005, 41: 738-746. 10.1002/hep.20616.CrossRefPubMed Venneman NG, Renooij W, Rehfeld JF, van Berge-Henegouwen GP, Go PMNYH, Broeders IAMJ, van Erpecum KJ: Small Gallstones, Preserved Gallbladder Motility, and Fast Crystallization Are Associated with Pancreatitis. Hepatology. 2005, 41: 738-746. 10.1002/hep.20616.CrossRefPubMed
8.
go back to reference Wang DQ, Afdhal NH: Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep. 2004, 6: 140-150.CrossRefPubMed Wang DQ, Afdhal NH: Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep. 2004, 6: 140-150.CrossRefPubMed
9.
go back to reference Trauner M, Boyer JL: Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003, 83: 633-671.CrossRefPubMed Trauner M, Boyer JL: Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003, 83: 633-671.CrossRefPubMed
10.
go back to reference Kullak-Ublick GA, Stieger B, Meier PJ: Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 2004, 126: 322-342. 10.1053/j.gastro.2003.06.005.CrossRefPubMed Kullak-Ublick GA, Stieger B, Meier PJ: Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 2004, 126: 322-342. 10.1053/j.gastro.2003.06.005.CrossRefPubMed
11.
go back to reference Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem. 2005, 280: 8742-8747. 10.1074/jbc.M411080200.CrossRefPubMed Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem. 2005, 280: 8742-8747. 10.1074/jbc.M411080200.CrossRefPubMed
12.
go back to reference Moschetta A, Bookout AL, Mangelsdorf DJ: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med. 2004, 10: 1352-1358. 10.1038/nm1138.CrossRefPubMed Moschetta A, Bookout AL, Mangelsdorf DJ: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med. 2004, 10: 1352-1358. 10.1038/nm1138.CrossRefPubMed
13.
go back to reference Wang HH, Portinacase P, Wang DQ: Prevention of Cholesterol (Ch) Gallstones by the Potent Ch Absorption Inhibitor Ezetimibe in Gallstone-Susceptible Mice. Gastroenterology. 2006, 130: A591-10.1053/j.gastro.2006.01.023.CrossRef Wang HH, Portinacase P, Wang DQ: Prevention of Cholesterol (Ch) Gallstones by the Potent Ch Absorption Inhibitor Ezetimibe in Gallstone-Susceptible Mice. Gastroenterology. 2006, 130: A591-10.1053/j.gastro.2006.01.023.CrossRef
14.
go back to reference Paigen B, Carey MC: Gallstones. The genetic basis of common diseases. Edited by: King RA. 2002, London, Oxford University Press, 298-335. Paigen B, Carey MC: Gallstones. The genetic basis of common diseases. Edited by: King RA. 2002, London, Oxford University Press, 298-335.
15.
go back to reference Angwafo FF, Takongmo S, Griffith D: Determination of chemical composition of gall bladder stones: basis for treatment strategies in patients from Yaounde, Cameroon. World J Gastroenterol. 2004, 10: 303-305.PubMed Angwafo FF, Takongmo S, Griffith D: Determination of chemical composition of gall bladder stones: basis for treatment strategies in patients from Yaounde, Cameroon. World J Gastroenterol. 2004, 10: 303-305.PubMed
16.
go back to reference Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ: Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995, 40: 1963-1973. 10.1007/BF02208665.CrossRefPubMed Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ: Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995, 40: 1963-1973. 10.1007/BF02208665.CrossRefPubMed
17.
go back to reference Tsai WL, Lai KH, Lin CK, Chan HH, Lo CC, Hsu PI, Chen WC, Cheng JS, Lo GH: Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy. World J Gastroenterol. 2005, 11: 4246-4249.CrossRefPubMedPubMedCentral Tsai WL, Lai KH, Lin CK, Chan HH, Lo CC, Hsu PI, Chen WC, Cheng JS, Lo GH: Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy. World J Gastroenterol. 2005, 11: 4246-4249.CrossRefPubMedPubMedCentral
18.
go back to reference Chihara G, Yamamoto S, Kameda H: Medical and biochemical application of infrared absorption spectra. I. Studies on gallstone by infrared spectra and X-ray chrystallography. Chem Pharm Bull (Tokyo). 1958, 6: 50-54.CrossRef Chihara G, Yamamoto S, Kameda H: Medical and biochemical application of infrared absorption spectra. I. Studies on gallstone by infrared spectra and X-ray chrystallography. Chem Pharm Bull (Tokyo). 1958, 6: 50-54.CrossRef
19.
go back to reference Trotman BW, Ostrow JD, Soloway RD: Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis. 1974, 19: 585-590. 10.1007/BF01073011.CrossRefPubMed Trotman BW, Ostrow JD, Soloway RD: Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis. 1974, 19: 585-590. 10.1007/BF01073011.CrossRefPubMed
20.
go back to reference Krawczak M, Nikolaus S, von Eberstein H, El Mokhtari NE, Schreiber S: PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 2006, 9: 55-61. 10.1159/000090694.PubMed Krawczak M, Nikolaus S, von Eberstein H, El Mokhtari NE, Schreiber S: PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 2006, 9: 55-61. 10.1159/000090694.PubMed
21.
go back to reference Malet PF, Williamson CE, Trotman BW, Soloway RD: Composition of pigmented centers of cholesterol gallstones. Hepatology. 1986, 6: 477-481.CrossRefPubMed Malet PF, Williamson CE, Trotman BW, Soloway RD: Composition of pigmented centers of cholesterol gallstones. Hepatology. 1986, 6: 477-481.CrossRefPubMed
22.
go back to reference Milne JW: Ion exchange in alkali halide disks. Spectrochim Acta. 1976, 32A: 1347-CrossRef Milne JW: Ion exchange in alkali halide disks. Spectrochim Acta. 1976, 32A: 1347-CrossRef
23.
go back to reference Ataman OY, Mark HB: Alkali Halide Pelleting Technique for Solid Sampling in Infrared Spectroscopy. Appl Spectroscopy Rev. 1977, 13: 1-CrossRef Ataman OY, Mark HB: Alkali Halide Pelleting Technique for Solid Sampling in Infrared Spectroscopy. Appl Spectroscopy Rev. 1977, 13: 1-CrossRef
24.
go back to reference Keresztury G, Insze M, Seti F, Imre L: CO2 inclusion bands in infrared spectra of KBr pellets. Spectrochim Acta. 1980, 36A: 1007-CrossRef Keresztury G, Insze M, Seti F, Imre L: CO2 inclusion bands in infrared spectra of KBr pellets. Spectrochim Acta. 1980, 36A: 1007-CrossRef
25.
go back to reference Malet PF, Weston NE, Trotman BW, Soloway RD: Cyclic deposition of calcium salts during growth of cholesterol gallstones. Scan Electron Microsc. 1985, 775-779. Malet PF, Weston NE, Trotman BW, Soloway RD: Cyclic deposition of calcium salts during growth of cholesterol gallstones. Scan Electron Microsc. 1985, 775-779.
26.
go back to reference Swidsinski A, Khilkin M, Pahlig H, Swidsinski S, Priem F: Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology. 1998, 27: 662-665. 10.1002/hep.510270304.CrossRefPubMed Swidsinski A, Khilkin M, Pahlig H, Swidsinski S, Priem F: Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology. 1998, 27: 662-665. 10.1002/hep.510270304.CrossRefPubMed
27.
go back to reference Gustafsson U, Sahlin S, Einarsson C: High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation. World J Gastroenterol. 2003, 9: 1576-1579.CrossRefPubMedPubMedCentral Gustafsson U, Sahlin S, Einarsson C: High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation. World J Gastroenterol. 2003, 9: 1576-1579.CrossRefPubMedPubMedCentral
28.
go back to reference Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C: Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005, 41: 1322-1328. 10.1002/hep.20686.CrossRefPubMed Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C: Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005, 41: 1322-1328. 10.1002/hep.20686.CrossRefPubMed
29.
go back to reference Venneman NG, Portincasa P, Vanberge-Henegouwen GP, van Erpecum KJ: Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile. Eur J Clin Invest. 2004, 34: 656-663. 10.1111/j.1365-2362.2004.01409.x.CrossRefPubMed Venneman NG, Portincasa P, Vanberge-Henegouwen GP, van Erpecum KJ: Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile. Eur J Clin Invest. 2004, 34: 656-663. 10.1111/j.1365-2362.2004.01409.x.CrossRefPubMed
30.
go back to reference Yago MD, Gonzalez V, Serrano P, Calpena R, Martinez MA, Martinez-Victoria E, Manas M: Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition. 2005, 21: 339-347. 10.1016/j.nut.2004.06.028.CrossRefPubMed Yago MD, Gonzalez V, Serrano P, Calpena R, Martinez MA, Martinez-Victoria E, Manas M: Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition. 2005, 21: 339-347. 10.1016/j.nut.2004.06.028.CrossRefPubMed
31.
go back to reference Taylor DR, Crowther RS, Cozart JC, Sharrock P, Wu J, Soloway RD: Calcium Carbonate in Cholesterol Gallstones: Polymorphism, Distribution and Hypothesis About Pathogenesis. Hepatology. 1995, 22: 488-496. 10.1016/0270-9139(95)90570-7.PubMed Taylor DR, Crowther RS, Cozart JC, Sharrock P, Wu J, Soloway RD: Calcium Carbonate in Cholesterol Gallstones: Polymorphism, Distribution and Hypothesis About Pathogenesis. Hepatology. 1995, 22: 488-496. 10.1016/0270-9139(95)90570-7.PubMed
32.
go back to reference Trotman BW, Soloway RD: Pigment Gallstone Disease: Summary of the National Institutes of Health - International Workshop. Hepatology. 1982, 2: 879-884.CrossRefPubMed Trotman BW, Soloway RD: Pigment Gallstone Disease: Summary of the National Institutes of Health - International Workshop. Hepatology. 1982, 2: 879-884.CrossRefPubMed
33.
go back to reference Stringer MD, Taylor DR, Soloway RD: Gallstone composition: are children different?. J Pediatr. 2003, 142: 435-440. 10.1067/mpd.2003.159.CrossRefPubMed Stringer MD, Taylor DR, Soloway RD: Gallstone composition: are children different?. J Pediatr. 2003, 142: 435-440. 10.1067/mpd.2003.159.CrossRefPubMed
34.
go back to reference Kleiner O, Ramesh J, Huleihel M, Cohen B, Kantarovich K, Levi C, Polyak B, Marks RS, Mordehai J, Cohen Z, Mordechai S: A comparative study of gallstones from children and adults using FTIR spectroscopy and fluorescence microscopy. BMC Gastroenterol. 2002, 2: 3-10.1186/1471-230X-2-3.CrossRefPubMedPubMedCentral Kleiner O, Ramesh J, Huleihel M, Cohen B, Kantarovich K, Levi C, Polyak B, Marks RS, Mordehai J, Cohen Z, Mordechai S: A comparative study of gallstones from children and adults using FTIR spectroscopy and fluorescence microscopy. BMC Gastroenterol. 2002, 2: 3-10.1186/1471-230X-2-3.CrossRefPubMedPubMedCentral
35.
go back to reference Friedman GD, Kannel WB, Dawler TR: The epidemiology of gallstone disease: Observations in the Framingham study. J Chronic Dis. 1966, 19: 273-292. 10.1016/0021-9681(66)90132-9.CrossRefPubMed Friedman GD, Kannel WB, Dawler TR: The epidemiology of gallstone disease: Observations in the Framingham study. J Chronic Dis. 1966, 19: 273-292. 10.1016/0021-9681(66)90132-9.CrossRefPubMed
36.
go back to reference van Erpecum KJ, van Berge Henegouwen GP, Stoelwinder B, Stolk MF, Eggink WF, Govaert WH: Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol. 1988, 23: 948-954.CrossRefPubMed van Erpecum KJ, van Berge Henegouwen GP, Stoelwinder B, Stolk MF, Eggink WF, Govaert WH: Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol. 1988, 23: 948-954.CrossRefPubMed
Metadata
Title
Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany
Authors
Clemens Schafmayer
Jürgen Hartleb
Jürgen Tepel
Stefan Albers
Sandra Freitag
Henry Völzke
Stephan Buch
Markus Seeger
Birgit Timm
Bernd Kremer
Ulrich R Fölsch
Fred Fändrich
Michael Krawczak
Stefan Schreiber
Jochen Hampe
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2006
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-6-36

Other articles of this Issue 1/2006

BMC Gastroenterology 1/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.